CAD 0.56
(3.7%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 621.07 Million USD | 28.47% |
2022 | 483.45 Million USD | -2.3% |
2021 | 494.82 Million USD | 38.4% |
2020 | 357.52 Million USD | 315.56% |
2019 | 86.03 Million CAD | 123128.98% |
2018 | 69.81 Thousand CAD | -79.41% |
2017 | 339.12 Thousand CAD | 35.31% |
2016 | 250.63 Thousand CAD | 35.79% |
2015 | 184.57 Thousand CAD | 651.32% |
2014 | 24.56 Thousand CAD | -62.24% |
2013 | 65.05 Thousand CAD | -56.19% |
2012 | 148.51 Thousand CAD | -6.75% |
2011 | 159.26 Thousand CAD | 16.61% |
2010 | 136.58 Thousand CAD | 1585.72% |
2009 | 8102.49 CAD | 38.7% |
2008 | 5841.86 CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 481.43 Million USD | -22.48% |
2024 Q2 | 479.01 Million USD | -0.5% |
2023 Q2 | 474.01 Million USD | -2.12% |
2023 Q1 | 484.27 Million USD | 0.17% |
2023 FY | 621.07 Million USD | 28.47% |
2023 Q3 | 480.84 Million USD | 1.44% |
2023 Q4 | 621.07 Million USD | 29.17% |
2022 Q3 | 487.95 Million USD | 0.87% |
2022 Q4 | 483.45 Million USD | -0.92% |
2022 FY | 483.45 Million USD | -2.3% |
2022 Q1 | 487.85 Million USD | -1.41% |
2022 Q2 | 483.76 Million USD | -0.84% |
2021 Q4 | 494.82 Million USD | 8.35% |
2021 Q2 | 416.38 Million USD | 9.73% |
2021 Q1 | 379.44 Million USD | 6.13% |
2021 Q3 | 456.67 Million USD | 9.68% |
2021 FY | 494.82 Million USD | 38.4% |
2020 Q3 | 231.59 Million USD | 66.28% |
2020 Q4 | 357.52 Million USD | 54.38% |
2020 Q2 | 139.27 Million USD | 24.3% |
2020 FY | 357.52 Million USD | 315.56% |
2020 Q1 | 112.04 Million USD | 30.24% |
2019 Q4 | 86.03 Million CAD | 85.99% |
2019 Q3 | 46.25 Million CAD | 209.46% |
2019 Q1 | 11.16 Million CAD | 24902.47% |
2019 Q2 | 14.94 Million CAD | 33.87% |
2019 FY | 86.03 Million CAD | 123128.98% |
2018 Q3 | 65.83 Thousand CAD | -81.36% |
2018 FY | 69.81 Thousand CAD | -79.41% |
2018 Q2 | 353.12 Thousand CAD | 4.13% |
2018 Q1 | 339.12 Thousand CAD | 49.96% |
2018 Q4 | 44.65 Thousand CAD | -32.16% |
2017 Q1 | 250.63 Thousand CAD | 0.0% |
2017 Q3 | 234.58 Thousand CAD | -4.29% |
2017 Q4 | 226.14 Thousand CAD | -3.6% |
2017 Q2 | 245.09 Thousand CAD | -2.21% |
2017 FY | 339.12 Thousand CAD | 35.31% |
2016 FY | 250.63 Thousand CAD | 35.79% |
2016 Q1 | 184.57 Thousand CAD | 6.8% |
2015 Q1 | 24.56 Thousand CAD | -58.38% |
2015 Q4 | 172.81 Thousand CAD | 21.54% |
2015 FY | 184.57 Thousand CAD | 651.32% |
2015 Q3 | 142.19 Thousand CAD | 246.92% |
2015 Q2 | 40.98 Thousand CAD | 66.85% |
2014 FY | 24.56 Thousand CAD | -62.24% |
2014 Q2 | 76.08 Thousand CAD | 16.94% |
2014 Q3 | 36.08 Thousand CAD | -52.57% |
2014 Q4 | 59.02 Thousand CAD | 63.57% |
2014 Q1 | 65.05 Thousand CAD | -42.19% |
2013 Q1 | 148.51 Thousand CAD | 10.53% |
2013 FY | 65.05 Thousand CAD | -56.19% |
2013 Q3 | 232.11 Thousand CAD | 148.2% |
2013 Q2 | 93.51 Thousand CAD | -37.03% |
2013 Q4 | 112.54 Thousand CAD | -51.51% |
2012 Q2 | 110.65 Thousand CAD | -30.52% |
2012 FY | 148.51 Thousand CAD | -6.75% |
2012 Q1 | 159.26 Thousand CAD | 2387.3% |
2012 Q4 | 134.36 Thousand CAD | -3.17% |
2012 Q3 | 138.75 Thousand CAD | 25.39% |
2011 Q3 | 35.09 Thousand CAD | -86.9% |
2011 Q1 | 136.58 Thousand CAD | 53.78% |
2011 Q2 | 267.77 Thousand CAD | 96.05% |
2011 Q4 | 6403.25 CAD | -81.75% |
2011 FY | 159.26 Thousand CAD | 16.61% |
2010 Q2 | 33.04 Thousand CAD | 156.98% |
2010 FY | 136.58 Thousand CAD | 1585.72% |
2010 Q3 | 95.99 Thousand CAD | 190.55% |
2010 Q4 | 88.81 Thousand CAD | -7.48% |
2010 Q1 | 12.85 Thousand CAD | 58.68% |
2009 Q1 | 11.85 Thousand CAD | 103.0% |
2009 FY | 8102.49 CAD | 38.7% |
2009 Q3 | 242.87 CAD | 0.27% |
2009 Q4 | 8102.49 CAD | 3236.18% |
2009 Q2 | 242.20 CAD | -97.96% |
2008 Q2 | - CAD | -100.0% |
2008 Q4 | 5841.86 CAD | 0.0% |
2008 FY | 5841.86 CAD | 0.0% |
2008 Q1 | 5101.52 CAD | 0.0% |
2008 Q3 | - CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aion Therapeutic Inc. | 2.93 Million CAD | -21050.331% |
Ayurcann Holdings Corp. | 14.31 Million CAD | -4237.447% |
Blueberries Medical Corp. | 470.72 Thousand CAD | -131841.515% |
The BC Bud Corporation | 626 Thousand CAD | -99113.273% |
BioNxt Solutions Inc. | 6.55 Million CAD | -9381.806% |
CordovaCann Corp. | 11.29 Million CAD | -5400.691% |
Christina Lake Cannabis Corp. | 8.5 Million CAD | -7205.945% |
Captor Capital Corp. | 28.76 Million CAD | -2059.183% |
City View Green Holdings Inc. | 3.73 Million CAD | -16537.652% |
1CM Inc. | 9.42 Million CAD | -6490.619% |
Global Hemp Group Inc. | 5.82 Million CAD | -10562.038% |
Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | -2833.205% |
IM Cannabis Corp. | 35.11 Million CAD | -1668.801% |
Lobe Sciences Ltd. | 2.45 Million CAD | -25151.037% |
Maple Leaf Green World Inc. | 10.08 Million CAD | -6060.919% |
Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -240628.318% |
Nextleaf Solutions Ltd. | 4.4 Million CAD | -14004.682% |
Ovation Science Inc. | 728.99 Thousand CAD | -85096.965% |
Pharmadrug Inc. | 2.92 Million CAD | -21130.061% |
Captiva Verde Wellness Corp. | 2.08 Million CAD | -29631.567% |
RAMM Pharma Corp. | 2.83 Million CAD | -21803.603% |
RIV Capital Inc. | 275.63 Million CAD | -125.325% |
Revive Therapeutics Ltd. | 3.4 Million CAD | -18145.92% |
Red White & Bloom Brands Inc. | 364.63 Million CAD | -70.327% |
SLANG Worldwide Inc. | 37.58 Million CAD | -1552.566% |
1933 Industries Inc. | 23.28 Million CAD | -2567.535% |
Red Light Holland Corp. | 3.82 Million CAD | -16151.56% |
Top Strike Resources Corp. | 20.99 Million CAD | -2858.365% |
Xebra Brands Ltd. | 789.95 Thousand CAD | -78522.081% |
Adastra Holdings Ltd. | 17.65 Million CAD | -3417.342% |